{"id":"W1974084711","doi":"10.1111/j.1464-410x.2005.05343.x","title":"An investigation of dose titration with darifenacin, an M <sub>3</sub> ‐selective receptor antagonist","year":2005,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":92,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Novartis Pharma; Novartis; Pfizer","keywords":"Tolerability; Overactive bladder; Placebo; Medicine; Adverse effect; Clinical endpoint; Urology; Anesthesia; Randomized controlled trial; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002119935,0.0004695766,0.001120743,0.0002275281,0.0001482878,0.0005058906,0.0007403289,0.0008361776,0.001594285],"category_scores_gemma":[0.003658143,0.0002887757,0.0007425807,0.0002571253,0.0005547862,0.000513207,0.00027564,0.001222718,0.0002441215],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003342968,"about_ca_system_score_gemma":0.0004219597,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000272981,"about_ca_topic_score_gemma":0.0003893508,"domain_scores_codex":[0.9986419,0.0008567293,0.0001000911,0.0001324198,0.0001934507,0.00007536231],"domain_scores_gemma":[0.9980862,0.0009600893,0.000510799,0.0001740887,0.00008871,0.0001800433],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6248474,0.02978298,0.009163085,0.001011136,0.0008762831,0.0001613299,0.000424619,0.002859061,0.08380187,0.000267687,0.00040097,0.2464038],"study_design_scores_gemma":[0.2216185,0.7409046,0.0190044,0.00006774405,0.0004370801,0.0002864646,0.00007570248,0.003874796,0.01146219,0.0001762302,0.002045919,0.00004638576],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9964361,0.001434136,0.0009151165,0.0000966304,0.00005544478,0.0005239284,0.00007392098,0.00002422432,0.0004403972],"genre_scores_gemma":[0.9950675,0.0006344543,0.003162438,0.0002209953,0.0001138846,0.0004658817,0.00008951264,0.00000699978,0.0002382891],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002119935,"threshold_uncertainty_score":0.0112114,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01496958975658132,"score_gpt":0.2775382184377896,"score_spread":0.2625686286812083,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}